Intralytix (United States)
Intralytix, Inc. is a privately owned biotech venture incorporated in the State of Maryland on July 28, 1998. Intralytix specializes in bacteriophage based products used to control bacterial pathogens in environmental, agricultural, food processing, and medical settings. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intralytix (United States), United States, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
66%
Total
Publications
74
Total Open
Publications
49
Total
Citations
4.7K
Open Access
Percentage
66%
Total
Publications
74
Total Open
Publications
49
Total
Citations
4.7K
Breakdown
Publisher Open
23%
Both
38%
Other Platform Open
7%
Closed
32%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 61%
29
Hybrid 8%
4
No Guarantees 31%
15
Other Platform Open
Domain 68%
25
Other Internet 30%
11
Institution 24%
9
Preprint 11%
4
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 25 |
DOI | Other Internet | 11 |
bioRxiv | Preprint | 3 |
Vrije Universiteit Amsterdam | Institution | 2 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
Europe PMC | Domain | 2 |
Office of Scientific and Technical Information | Institution | 1 |
medRxiv | Preprint | 1 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 1 |
KU Leuven | Institution | 1 |